Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
APTA Adds Its Voice to Multi-Organization Advocacy Efforts

May 11, 2021/Roundup

We're seizing opportunities to amplify our public policy messages — here's a sampling of some of the issue letters we've signed on to.

Guidelines to Promote Excellence in Clinical Education Partnerships

Sep 20, 2019/Policies & Bylaws

House guideline: Provides guidelines and describes aspects of the clinical partner site, the site coordinator of clinical education, and the clinical instructor that are necessary to promote excellence in clinical education.

Mercer U. Three-peats Student Advocacy Challenge Win

Mar 13, 2024/News

For the third year in a row, the Atlanta-based program takes home top honors thanks to its multilayered advocacy efforts.

Impact of Student Debt on the Physical Therapy Profession

Jun 1, 2020/Report

The report includes recommendations, as well as a summary of actions APTA has been taking to address the problem.

Succeeding on Social Media

Social media can be an effective tool for networking with colleagues, staying informed, or promoting yourself or your brand. But inappropriate behavior can be damaging. Here are some things to consider.

CMS Corrects RTM Code Denials Made in Error

Apr 14, 2023/News

APTA's outreach sparked the change, to be made official in July. Until then, denied claims should be resubmitted.

Global Deterioration Scale for Assessment of Primary Degenerative Dementia (GDS)

Aug 22, 2017/Test & Measure

A quick screening tool to detect the early onset of dementia as well as the severity of the condition.

Chronic Heart Failure in Adults: Diagnosis and Management [NG106]

Sep 12, 2018/CPG

This guideline provides recommendations related to the diagnosis and management of patients with chronic heart failure in people aged 18 and over.

Multiple Sclerosis in Adults: Management [NICE NG220]

Jun 22, 2022/CPG

This guideline covers diagnosing and managing multiple sclerosis in people aged 18 and over and aims to improve the quality of life for adults with multiple sclerosis. [Formerly NICE CG186.]